Biozen secures FDA 510(k) clearance for BP1000 device
Biozen plans to introduce BP1000 to the US market in phases, with broader commercial availability targeted for late 2026.
Educating the medical device manufacturing industry since 2002.
Biozen plans to introduce BP1000 to the US market in phases, with broader commercial availability targeted for late 2026.
To track and verify embodied emissions through every stage of the supply chain, leading OEMs are piloting blockchain-anchored digital product passports (DPPs). Ellie Philpotts talks to Chris Taylor, sustainability lead...
Go with the flow
Harnessing automation
How smart can it be?
Killer nanopatterns